Concepedia

Fenghao Shi

FS

Statistics

Publications

3

Citations

59

H-Index

3

Active since

2022

Affiliations

Peking University(Current)

China Pharmaceutical University

Fenghao Shi is an author at Peking University specializing in comparative cost-utility analysis, cost-effectiveness comparison, and model-based economic evaluation.

Publications per year

2022–2022

3

Publications

3

First-line treatments for advanced hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis in China and the United States

Kexin Sun, Shanshan Cao, Fenghao Shi et al. · Therapeutic Advances in Gastroenterology · 2022 · 29 citations · Full text

, , +17

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study

Fenghao Shi, Zixuan He, Lin Wang et al. · Frontiers in Pharmacology · 2022 · 18 citations · Full text

, , +17

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

Fenghao Shi, Zixuan He, Hang Su et al. · Frontiers in Pharmacology · 2022 · 12 citations · Full text

, , +17

1–3 of 3